Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Developing Measures To Access Compliance With Centers for Disease Control and Prevention (CDC)/Healthcare Infection Control Practices Advisory Committee (HICPAC) Recommendations for the Prevention of Healthcare Associated Methicillin Resistant Staphylococcus Aureus and Related Multidrug Resistant Organisms, Potential Extramural Project 2008-R-20, 33435 [E8-13183]

Download as PDF Federal Register / Vol. 73, No. 114 / Thursday, June 12, 2008 / Notices Contact Person for More Information: Charles Rafferty, PhD, Senior Scientific Reviewer Officer, Office of Science and Public Health Practice, Coordinating Office for Terrorism Preparedness and Emergency Response, CDC, 1600 Clifton Road, NE., Mailstop D44, Atlanta, GA 30333, Telephone (404) 639–7495. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 6, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–13178 Filed 6–11–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): CDC Grants for Public Health Research Dissertation (Panel A–2), Program Announcement (PAR) 07–231 mstockstill on PROD1PC66 with NOTICES In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 12 p.m.–4 p.m., July 16, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘CDC Grants for Public Health Research Dissertation (Panel A–2), PAR07– 231.’’ Contact Person for More Information: Sheree Marshall Williams, PhD, M.Sc., Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone (404) 639–4896. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. VerDate Aug<31>2005 21:47 Jun 11, 2008 Jkt 214001 Dated: June 6, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–13179 Filed 6–11–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Developing Measures To Access Compliance With Centers for Disease Control and Prevention (CDC)/Healthcare Infection Control Practices Advisory Committee (HICPAC) Recommendations for the Prevention of Healthcare Associated Methicillin Resistant Staphylococcus Aureus and Related Multidrug Resistant Organisms, Potential Extramural Project 2008–R–20 Correction: This notice was published in the Federal Register on April 16, 2008, Volume 73, Number 74, page 20678. The aforementioned meeting has been rescheduled to the following: Time and Date: 1 p.m.–3 p.m., June 17, 2008 (Closed). Contact Person for More Information: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, Atlanta, GA 30333. Telephone (404) 498–1194. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 6, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–13183 Filed 6–11–08; 8:45 am] BILLING CODE 4163–18–P PO 00000 33435 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Monitoring Hospitalization and Outpatient Visits for Pneumonia and Other Non-Invasive Pneumonococcal Diseases by Using National Databases, Potential Extramural Project 2008–R–17 Correction: This notice was published in the Federal Register on April 18, 2008, Volume 73, Number 76, page 21136. The aforementioned meeting has been rescheduled to the following: Time and Date: 1 p.m.–3 p.m., June 17, 2008 (Closed). Contact Person for More Information: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, Atlanta, GA 30333. Telephone (404) 498–1194. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 6, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–13184 Filed 6–11–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): CDC Grants for Public Health Research Dissertation (Panel A–3), Program Announcement (PAR) 07–231 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 12 p.m.–4 p.m., July 17, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 Frm 00049 Fmt 4703 Sfmt 4703 E:\FR\FM\12JNN1.SGM 12JNN1

Agencies

[Federal Register Volume 73, Number 114 (Thursday, June 12, 2008)]
[Notices]
[Page 33435]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-13183]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Developing Measures To Access Compliance With Centers 
for Disease Control and Prevention (CDC)/Healthcare Infection Control 
Practices Advisory Committee (HICPAC) Recommendations for the 
Prevention of Healthcare Associated Methicillin Resistant 
Staphylococcus Aureus and Related Multidrug Resistant Organisms, 
Potential Extramural Project 2008-R-20

    Correction: This notice was published in the Federal Register on 
April 16, 2008, Volume 73, Number 74, page 20678. The aforementioned 
meeting has been rescheduled to the following:
    Time and Date: 1 p.m.-3 p.m., June 17, 2008 (Closed).
    Contact Person for More Information: Linda Shelton, Program 
Specialist, Coordinating Center for Health and Information Service, 
Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, 
Atlanta, GA 30333. Telephone (404) 498-1194.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: June 6, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E8-13183 Filed 6-11-08; 8:45 am]
BILLING CODE 4163-18-P